ClinOmicsTrailbc

ClinOmicsTrailbc integrates clinical, (epi-)genomic, and transcriptomic data to stratify breast cancer treatments by evaluating driver mutations, tumor mutational burden, pathway activities, drug-specific biomarkers, molecular targets, pharmacogenomics, drug repositioning candidates, and immunotherapeutic options.

Key Features:

• Holistic treatment assessment: Evaluates standard-of-care targeted drugs, candidates for drug repositioning, and immunotherapeutic approaches for breast cancer.
• Multi-omics integration: Integrates clinical markers with (epi-)genomics and transcriptomics to identify driver mutations, tumor mutational burden, and core cancer-relevant pathway activity patterns.
• Biomarker and target analysis: Assesses drug-specific biomarkers, molecular drug target status, and pharmacogenomic influences to inform therapeutic selection.

Scientific Applications:

• Therapy stratification: Supports selection of personalized treatment options for breast cancer patients based on genomic and transcriptomic profiles.
• Biomarker and target discovery: Facilitates identification and evaluation of actionable driver mutations, biomarkers, and molecular drug targets.
• Translational research: Enables comparative analyses across cases to support research initiatives in breast cancer precision medicine.

Methodology:

Integration and visualization of clinical, genomic, and transcriptomic data combined with analyses of driver mutations, tumor mutational burden, pathway activities, and pharmacogenomics.